4-Chloro-6-methylpyrimidin-5-amine, 95.0%, 100mg

2-Butoxy-1,2-oxaborolane, 97%, 100mg

2-Formyl-1H-indole-6-carbonitrile, 95.0%, 1g

1-PHENYLIMIDAZOLIDIN-2-ONE, 95.0%, 1g

N-(4-Methoxybenzyl)cyclopropanamine, 97%, 5g

2-(Difluoromethoxy)pyridin-4-ol, 95.0%, 5g

tert-Butyl 5-aminohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate, 95.0%, 1g

4'-Cyanobenzylidene-4-ethoxyaniline>98.0%(T)1g

1,3-Dioxane>98.0%(GC)100mL

Thalidomide-NH-CH2-COOH, 1g

3-Acetyl-7-fluoro-2H-chromen-2-one, 98%, 1g

Unité de filtration avec membrane SFCA Taille des pores 0,45 μm, 250 ml, 250 ml, 50 mm, 12 pièce(s)

1-Bromo-2,4,5-trifluoro-3-methylbenzene, 95.0%, 1g